Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study

BACKGROUND: Immune checkpoint inhibitors (ICI) are associated with immune-mediated adverse effects, potentially involving any organ. ICI has also been associated with an increased risk of cardiovascular disease in cancer populations. OBJECTIVE: To characterize the incidence and risk of major atheros...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Charlie, Zoungas, Sophia, Yan, Mabel, Wolfe, Rory, Haydon, Andrew, Shackleton, Mark, Voskoboynik, Mark, Moore, Maggie, Andrews, Miles C., Nicholls, Stephen J., Mar, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716700/
https://www.ncbi.nlm.nih.gov/pubmed/36461057
http://dx.doi.org/10.1186/s40959-022-00149-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716700/
https://www.ncbi.nlm.nih.gov/pubmed/36461057
http://dx.doi.org/10.1186/s40959-022-00149-8

Ejemplares similares